Clinical Trial Update: Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update announcing completion of a study of the monoclonal antibody ABX-EGF in patients with multiple cancers, including non-small cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Esophageal Cancer
• Gastroesophageal Junction Cancer
• Kidney Cancer
• Non-small Cell Lung Cancer
• Pancreatic Cancer
• Prostate Cancer

Drugs mentioned

• ABX-EGF (panitumumab)

Snippet

Sponsor: Jonsson Comprehensive Cancer Center | Conditions: Colorectal Cancer, Esophageal Cancer | Phase 1 | Status: COMPLETED